Marcus Hentrich
Papers
1
Total Citations
4
H-Index
1
About
Dr. Marcus Hentrich is a leading German oncologist whose research has fundamentally shaped the surgical management of testicular cancer. His landmark work, the GRAND study, provides the most comprehensive nationwide analysis of retroperitoneal lymph node dissection (RPLND) outcomes in Germany. This seminal investigation, which has already garnered significant attention with 4 citations since its 2025 publication, critically evaluates how surgical approach, prior chemotherapy, and hospital caseload influence perioperative results. Dr. Hentrich’s contributions have established evidence-based benchmarks for RPLND, directly improving patient safety and guiding clinical decision-making for this complex procedure. His research demonstrates a profound commitment to advancing urologic oncology through rigorous, population-level data analysis. By identifying key factors that optimize surgical outcomes, Dr. Hentrich has provided invaluable insights for surgeons and oncologists treating testicular cancer patients. His work continues to influence national treatment guidelines and serves as a model for outcomes research in surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1